Collen D - Search Results

1

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D. Holvoet P, et al. Among authors: collen d. J Clin Invest. 1995 Jun;95(6):2611-9. doi: 10.1172/JCI117963. J Clin Invest. 1995. PMID: 7769103 Free PMC article.

2

Oxidized lipoproteins in atherosclerosis and thrombosis.

Holvoet P, Collen D. Holvoet P, et al. Among authors: collen d. FASEB J. 1994 Dec;8(15):1279-84. doi: 10.1096/fasebj.8.15.8001740. FASEB J. 1994. PMID: 8001740 Review.

3

Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.

Holvoet P, Perez G, Bernar H, Brouwers E, Vanloo B, Rosseneu M, Collen D. Holvoet P, et al. Among authors: collen d. J Clin Invest. 1994 Jan;93(1):89-98. doi: 10.1172/JCI116988. J Clin Invest. 1994. PMID: 8282826 Free PMC article.

4

Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.

Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. Holvoet P, et al. Among authors: collen d. Thromb Haemost. 1996 Nov;76(5):663-9. Thromb Haemost. 1996. PMID: 8950769

5

beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits.

Holvoet P, Collen D. Holvoet P, et al. Among authors: collen d. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2376-82. doi: 10.1161/01.atv.17.11.2376. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409204

6

Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

Holvoet P, Danloy S, Deridder E, Lox M, Bernar H, Dhoest A, Collen D. Holvoet P, et al. Among authors: collen d. J Clin Invest. 1998 Jul 15;102(2):379-85. doi: 10.1172/JCI3038. J Clin Invest. 1998. PMID: 9664079 Free PMC article.

7

Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.

Holvoet P, Collen D. Holvoet P, et al. Among authors: collen d. Atherosclerosis. 1998 Apr;137 Suppl:S33-8. doi: 10.1016/s0021-9150(97)00305-5. Atherosclerosis. 1998. PMID: 9694539 Review.

8

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Holvoet P, et al. Among authors: collen d. Circulation. 1998 Oct 13;98(15):1487-94. doi: 10.1161/01.cir.98.15.1487. Circulation. 1998. PMID: 9769301 Free article.

9

Malondialdehyde-modified LDL as a marker of acute coronary syndromes.

Holvoet P, Collen D, Van de Werf F. Holvoet P, et al. Among authors: collen d. JAMA. 1999 May 12;281(18):1718-21. doi: 10.1001/jama.281.18.1718. JAMA. 1999. PMID: 10328072

10

Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association.

Holvoet P, Zhao Z, Deridder E, Dhoest A, Collen D. Holvoet P, et al. Among authors: collen d. J Biol Chem. 1996 Aug 9;271(32):19395-401. doi: 10.1074/jbc.271.32.19395. J Biol Chem. 1996. PMID: 8702626 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters